280 related articles for article (PubMed ID: 25751301)
1. Cell type-specific expression profile and signaling requirements in early hematopoietic reprogramming.
Kang L; Wu J; Tao Y; Li H; Liu X; Gao S; Wang QF
Stem Cells Dev; 2015 Jun; 24(12):1483-92. PubMed ID: 25751301
[TBL] [Abstract][Full Text] [Related]
2. Pluripotent cell models of fanconi anemia identify the early pathological defect in human hemoangiogenic progenitors.
Suzuki NM; Niwa A; Yabe M; Hira A; Okada C; Amano N; Watanabe A; Watanabe K; Heike T; Takata M; Nakahata T; Saito MK
Stem Cells Transl Med; 2015 Apr; 4(4):333-8. PubMed ID: 25762002
[TBL] [Abstract][Full Text] [Related]
3. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
4. Somatic cells with a heavy mitochondrial DNA mutational load render induced pluripotent stem cells with distinct differentiation defects.
Wahlestedt M; Ameur A; Moraghebi R; Norddahl GL; Sten G; Woods NB; Bryder D
Stem Cells; 2014 May; 32(5):1173-82. PubMed ID: 24446123
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells.
Gao S; Tao L; Hou X; Xu Z; Liu W; Zhao K; Guo M; Wang H; Cai T; Tian J; Gao S; Chang G
Stem Cell Res Ther; 2016 Mar; 7():40. PubMed ID: 26979597
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity.
Nishizawa M; Chonabayashi K; Nomura M; Tanaka A; Nakamura M; Inagaki A; Nishikawa M; Takei I; Oishi A; Tanabe K; Ohnuki M; Yokota H; Koyanagi-Aoi M; Okita K; Watanabe A; Takaori-Kondo A; Yamanaka S; Yoshida Y
Cell Stem Cell; 2016 Sep; 19(3):341-54. PubMed ID: 27476965
[TBL] [Abstract][Full Text] [Related]
7. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
[TBL] [Abstract][Full Text] [Related]
8. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
9. Single-cell transcriptome analysis reveals dynamic changes in lncRNA expression during reprogramming.
Kim DH; Marinov GK; Pepke S; Singer ZS; He P; Williams B; Schroth GP; Elowitz MB; Wold BJ
Cell Stem Cell; 2015 Jan; 16(1):88-101. PubMed ID: 25575081
[TBL] [Abstract][Full Text] [Related]
10. Re-entering the pluripotent state from blood lineage: promises and pitfalls of blood reprogramming.
Chen Y; Yi Y; Xu J; Chan WK; Loh YH
FEBS Lett; 2019 Dec; 593(23):3244-3252. PubMed ID: 31691960
[TBL] [Abstract][Full Text] [Related]
11. Haematopoietic stem cell reprogramming and the hope for a universal blood product.
Barcia Durán JG; Lis R; Rafii S
FEBS Lett; 2019 Dec; 593(23):3253-3265. PubMed ID: 31725897
[TBL] [Abstract][Full Text] [Related]
12. Time-course transcriptome analysis of human cellular reprogramming from multiple cell types reveals the drastic change occurs between the mid phase and the late phase.
Kuno A; Nishimura K; Takahashi S
BMC Genomics; 2018 Jan; 19(1):9. PubMed ID: 29298685
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of somatic and pluripotent cells reveals novel pathways involved in reprogramming.
Cai YN; Dai XH; Zhang QH; Hu R; Dai ZM
Genet Mol Res; 2015 Oct; 14(4):12085-92. PubMed ID: 26505355
[TBL] [Abstract][Full Text] [Related]
14. Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic coculture.
Daniel MG; Sachs D; Bernitz JM; Fstkchyan Y; Rapp K; Satija N; Law K; Patel F; Gomes AM; Kim HS; Pereira CF; Chen B; Lemischka IR; Moore KA
FEBS Lett; 2019 Dec; 593(23):3266-3287. PubMed ID: 31557312
[TBL] [Abstract][Full Text] [Related]
15. Development of a High-Efficacy Reprogramming Method for Generating Human Induced Pluripotent Stem (iPS) Cells from Pathologic and Senescent Somatic Cells.
Tanaka N; Kato H; Tsuda H; Sato Y; Muramatsu T; Iguchi A; Nakajima H; Yoshitake A; Senbonmatsu T
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942642
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Lnk in mouse induced pluripotent stem cells promotes hematopoietic cell generation.
Tashiro K; Omori M; Kawabata K; Hirata N; Yamaguchi T; Sakurai F; Takaki S; Mizuguchi H
Stem Cells Dev; 2012 Dec; 21(18):3381-90. PubMed ID: 22738147
[TBL] [Abstract][Full Text] [Related]
17. Clonal reversal of ageing-associated stem cell lineage bias via a pluripotent intermediate.
Wahlestedt M; Erlandsson E; Kristiansen T; Lu R; Brakebusch C; Weissman IL; Yuan J; Martin-Gonzalez J; Bryder D
Nat Commun; 2017 Feb; 8():14533. PubMed ID: 28224997
[TBL] [Abstract][Full Text] [Related]
18. Wnt3a protein reduces growth factor-driven expansion of human hematopoietic stem and progenitor cells in serum-free cultures.
Duinhouwer LE; Tüysüz N; Rombouts EW; Ter Borg MN; Mastrobattista E; Spanholtz J; Cornelissen JJ; Ten Berge D; Braakman E
PLoS One; 2015; 10(3):e0119086. PubMed ID: 25807521
[TBL] [Abstract][Full Text] [Related]
19. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
Ebrahimi B
Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial modulation of signaling pathways reveals cell-type-specific requirements for highly efficient and synchronous iPSC reprogramming.
Vidal SE; Amlani B; Chen T; Tsirigos A; Stadtfeld M
Stem Cell Reports; 2014 Oct; 3(4):574-84. PubMed ID: 25358786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
